{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:22:38Z","timestamp":1776831758082,"version":"3.51.2"},"reference-count":77,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association (AHA)","doi-asserted-by":"publisher","award":["20PRE35200228"],"award-info":[{"award-number":["20PRE35200228"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association (AHA)","doi-asserted-by":"publisher","award":["R01CA238946"],"award-info":[{"award-number":["R01CA238946"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association (AHA)","doi-asserted-by":"publisher","award":["R01CA215802"],"award-info":[{"award-number":["R01CA215802"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association (AHA)","doi-asserted-by":"publisher","award":["R01HL155378"],"award-info":[{"award-number":["R01HL155378"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association (AHA)","doi-asserted-by":"publisher","award":["R01NS121234"],"award-info":[{"award-number":["R01NS121234"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association (AHA)","doi-asserted-by":"publisher","award":["U24CA247648"],"award-info":[{"award-number":["U24CA247648"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["20PRE35200228"],"award-info":[{"award-number":["20PRE35200228"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R01CA238946"],"award-info":[{"award-number":["R01CA238946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R01CA215802"],"award-info":[{"award-number":["R01CA215802"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R01HL155378"],"award-info":[{"award-number":["R01HL155378"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R01NS121234"],"award-info":[{"award-number":["R01NS121234"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["U24CA247648"],"award-info":[{"award-number":["U24CA247648"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"OSU Comprehensive Cancer Center","award":["20PRE35200228"],"award-info":[{"award-number":["20PRE35200228"]}]},{"name":"OSU Comprehensive Cancer Center","award":["R01CA238946"],"award-info":[{"award-number":["R01CA238946"]}]},{"name":"OSU Comprehensive Cancer Center","award":["R01CA215802"],"award-info":[{"award-number":["R01CA215802"]}]},{"name":"OSU Comprehensive Cancer Center","award":["R01HL155378"],"award-info":[{"award-number":["R01HL155378"]}]},{"name":"OSU Comprehensive Cancer Center","award":["R01NS121234"],"award-info":[{"award-number":["R01NS121234"]}]},{"name":"OSU Comprehensive Cancer Center","award":["U24CA247648"],"award-info":[{"award-number":["U24CA247648"]}]},{"name":"Experimental Therapeutics Clinical Trials Network (ETCTN)","award":["20PRE35200228"],"award-info":[{"award-number":["20PRE35200228"]}]},{"name":"Experimental Therapeutics Clinical Trials Network (ETCTN)","award":["R01CA238946"],"award-info":[{"award-number":["R01CA238946"]}]},{"name":"Experimental Therapeutics Clinical Trials Network (ETCTN)","award":["R01CA215802"],"award-info":[{"award-number":["R01CA215802"]}]},{"name":"Experimental Therapeutics Clinical Trials Network (ETCTN)","award":["R01HL155378"],"award-info":[{"award-number":["R01HL155378"]}]},{"name":"Experimental Therapeutics Clinical Trials Network (ETCTN)","award":["R01NS121234"],"award-info":[{"award-number":["R01NS121234"]}]},{"name":"Experimental Therapeutics Clinical Trials Network (ETCTN)","award":["U24CA247648"],"award-info":[{"award-number":["U24CA247648"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Dofetilide is a rapid delayed rectifier potassium current inhibitor widely used to prevent the recurrence of atrial fibrillation and flutter. The clinical use of this drug is associated with increases in QTc interval, which predispose patients to ventricular cardiac arrhythmias. The mechanisms involved in the disposition of dofetilide, including its movement in and out of cardiomyocytes, remain unknown. Using a xenobiotic transporter screen, we identified MATE1 (SLC47A1) as a transporter of dofetilide and found that genetic knockout or pharmacological inhibition of MATE1 in mice was associated with enhanced retention of dofetilide in cardiomyocytes and increased QTc prolongation. The urinary excretion of dofetilide was also dependent on the MATE1 genotype, and we found that this transport mechanism provides a mechanistic basis for previously recorded drug-drug interactions of dofetilide with various contraindicated drugs, including bictegravir, cimetidine, ketoconazole, and verapamil. The translational significance of these observations was examined with a physiologically-based pharmacokinetic model that adequately predicted the drug-drug interaction liabilities in humans. These findings support the thesis that MATE1 serves a conserved cardioprotective role by restricting excessive cellular accumulation and warrant caution against the concurrent administration of potent MATE1 inhibitors and cardiotoxic substrates with a narrow therapeutic window.<\/jats:p>","DOI":"10.3390\/ijms23158607","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T20:52:01Z","timestamp":1659559921000},"page":"8607","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7160-0455","authenticated-orcid":false,"given":"Muhammad Erfan","family":"Uddin","sequence":"first","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-675X","authenticated-orcid":false,"given":"Eric D.","family":"Eisenmann","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9055-2332","authenticated-orcid":false,"given":"Yang","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7250-9346","authenticated-orcid":false,"given":"Dominique A.","family":"Garrison","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Talebi","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice A.","family":"Gibson","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-3362","authenticated-orcid":false,"given":"Yan","family":"Jin","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7259-2699","authenticated-orcid":false,"given":"Mahesh","family":"Nepal","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1435-3870","authenticated-orcid":false,"given":"Ingrid M.","family":"Bonilla","sequence":"additional","affiliation":[{"name":"Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Sun","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alec","family":"Millar","sequence":"additional","affiliation":[{"name":"Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Tarasov","sequence":"additional","affiliation":[{"name":"Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher E.","family":"Jay","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3091-7496","authenticated-orcid":false,"given":"Xiaoming","family":"Cui","sequence":"additional","affiliation":[{"name":"Novartis Institute for Biomedical Research, East Hanover, NJ 07936, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi J.","family":"Einolf","sequence":"additional","affiliation":[{"name":"Novartis Institute for Biomedical Research, East Hanover, NJ 07936, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan M.","family":"Pelis","sequence":"additional","affiliation":[{"name":"Novartis Institute for Biomedical Research, East Hanover, NJ 07936, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakima A.","family":"Smith","sequence":"additional","affiliation":[{"name":"OSU Wexner Medical Center, Department of Internal Medicine, Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0750-2308","authenticated-orcid":false,"given":"Przemys\u0142aw B.","family":"Radwa\u0144ski","sequence":"additional","affiliation":[{"name":"Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8911-9184","authenticated-orcid":false,"given":"Douglas H.","family":"Sweet","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-5482","authenticated-orcid":false,"given":"J\u00f6rg","family":"K\u00f6nig","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0334-7478","authenticated-orcid":false,"given":"Martin F.","family":"Fromm","sequence":"additional","affiliation":[{"name":"Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia A.","family":"Carnes","sequence":"additional","affiliation":[{"name":"Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA"},{"name":"Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9806-7734","authenticated-orcid":false,"given":"Shuiying","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2660-6644","authenticated-orcid":false,"given":"Alex","family":"Sparreboom","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing Prevalence of Atrial Fibrillation and Flutter in the United States","volume":"104","author":"Naccarelli","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_2","first-page":"195","article-title":"Atrial Fibrillation: The Current Epidemic","volume":"14","author":"Morillo","year":"2017","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the Number of Individuals with Atrial Fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e000102","DOI":"10.1161\/JAHA.112.000102","article-title":"Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: The CHARGE-AF Consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global Epidemiology of Atrial Fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/europace\/eun130","article-title":"Anti-Arrhythmic Drug Therapy for Atrial Fibrillation: Current Anti-Arrhythmic Drugs, Investigational Agents, and Innovative Approaches","volume":"10","author":"Savelieva","year":"2008","journal-title":"Europace"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1053\/euhj.1999.2039","article-title":"Comparison of Intravenously Administered Dofetilide versus Amiodarone in the Acute Termination of Atrial Fibrillation and Flutter. A Multicentre, Randomized, Double-Blind, Placebo-Controlled Study","volume":"21","author":"Bianconi","year":"2000","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1074248418784288","article-title":"A Quarter of a Century Later: What Is Dofetilide\u2019s Clinical Role Today?","volume":"24","author":"Wolbrette","year":"2019","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ihj.2013.12.021","article-title":"Dofetilide Induced Torsade de Pointes: Mechanism, Risk Factors and Management Strategies","volume":"66","author":"Jaiswal","year":"2014","journal-title":"Indian Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.hrthm.2018.01.027","article-title":"Dofetilide Dose Reductions and Discontinuations in Women Compared with Men","volume":"15","author":"Pokorney","year":"2018","journal-title":"Heart Rhythm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccep.2016.02.006","article-title":"Dofetilide: Electrophysiologic Effect, Efficacy, and Safety in Patients with Cardiac Arrhythmias","volume":"8","author":"Shenasa","year":"2016","journal-title":"Card Electrophysiol. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2004.07.098","article-title":"Human Organic Cation Transporter 3 Mediates the Transport of Antiarrhythmic Drugs","volume":"499","author":"Hasannejad","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/CIRCULATIONAHA.105.586107","article-title":"Uptake of Cardiovascular Drugs into the Human Heart: Expression, Regulation, and Function of the Carnitine Transporter OCTN2 (SLC22A5)","volume":"113","author":"Grube","year":"2006","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/FJC.0b013e3181abc288","article-title":"The Organic Cation Transporter, OCTN1, Expressed in the Human Heart, Potentiates Antagonism of the HERG Potassium Channel","volume":"54","author":"McBride","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"17923","DOI":"10.1073\/pnas.0506483102","article-title":"A Human Transporter Protein That Mediates the Final Excretion Step for Toxic Organic Cations","volume":"102","author":"Otsuka","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"C678","DOI":"10.1152\/ajpcell.00090.2006","article-title":"Wide Variety of Locations for Rodent MATE1, a Transporter Protein That Mediates the Final Excretion Step for Toxic Organic Cations","volume":"291","author":"Hiasa","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"27055","DOI":"10.1074\/jbc.M114.570564","article-title":"Taste of a Pill: Organic Cation Transporter-3 (OCT3) Mediates Metformin Accumulation and Secretion in Salivary Glands","volume":"289","author":"Lee","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.107.123554","article-title":"Transport of Paraquat by Human Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Family","volume":"322","author":"Chen","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1124\/mol.109.056242","article-title":"Targeted Disruption of the Multidrug and Toxin Extrusion 1 (Mate1) Gene in Mice Reduces Renal Secretion of Metformin","volume":"75","author":"Tsuda","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/jpet.108.147918","article-title":"Involvement of Human Multidrug and Toxin Extrusion 1 in the Drug Interaction between Cimetidine and Metformin in Renal Epithelial Cells","volume":"329","author":"Tsuda","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1476-5381.2011.01394.x","article-title":"Importance of the Multidrug and Toxin Extrusion MATE\/SLC47A Family to Pharmacokinetics, Pharmacodynamics\/Toxicodynamics and Pharmacogenomics","volume":"164","author":"Yonezawa","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/dom.12577","article-title":"Inhibition of the Multidrug and Toxin Extrusion (MATE) Transporter by Pyrimethamine Increases the Plasma Concentration of Metformin but Does Not Increase Antihyperglycaemic Activity in Humans","volume":"18","author":"Oh","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"ref_24","first-page":"447","article-title":"Significance of Metabolism in the Disposition and Action of the Antidysrhythmic Drug, Dofetilide. In Vitro Studies and Correlation with in Vivo Data","volume":"24","author":"Walker","year":"1996","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.yjmcc.2011.02.018","article-title":"Retrograde Heart Perfusion: The Langendorff Technique of Isolated Heart Perfusion","volume":"50","author":"Bell","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1113\/jphysiol.1997.sp022021","article-title":"Dual Effects of Tetracaine on Spontaneous Calcium Release in Rat Ventricular Myocytes","volume":"500","author":"Lukyanenko","year":"1997","journal-title":"J. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"C1437","DOI":"10.1152\/ajpcell.00280.2007","article-title":"Functional Characterization of Testis-Specific Rodent Multidrug and Toxic Compound Extrusion 2, a Class III MATE-Type Polyspecific H+\/Organic Cation Exporter","volume":"293","author":"Hiasa","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1172\/JCI136796","article-title":"Neuronal Uptake Transporters Contribute to Oxaliplatin Neurotoxicity in Mice","volume":"130","author":"Huang","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1161\/01.CIR.102.21.2665","article-title":"DiMarco Dofetilide","volume":"102","author":"John","year":"2000","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2125.2000.00243.x","article-title":"The Pharmacokinetics and Pharmacodynamics of Oral Dofetilide after Twice Daily and Three Times Daily Dosing","volume":"50","author":"Allen","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"C73","DOI":"10.1152\/ajpcell.2000.278.1.C73","article-title":"Age-Dependent Response of the Electrocardiogram to K(+) Channel Blockers in Mice","volume":"278","author":"Wang","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3949\/ccjm.68.4.353","article-title":"Dofetilide (Tikosyn): A New Drug to Control Atrial Fibrillation","volume":"68","author":"Saliba","year":"2001","journal-title":"Cleve. Clin. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2165\/00003495-199958060-00007","article-title":"Dofetilide: A Review of Its Use in Atrial Fibrillation and Atrial Flutter","volume":"58","author":"McClellan","year":"1999","journal-title":"Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/pharmaceutics4020314","article-title":"Expression Profile of Drug and Nutrient Absorption Related Genes in Madin-Darby Canine Kidney (MDCK) Cells Grown under Differentiation Conditions","volume":"4","author":"Quan","year":"2012","journal-title":"Pharmaceutics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1015807904558","article-title":"The Madin Darby Canine Kidney (MDCK) Epithelial Cell Monolayer as a Model Cellular Transport Barrier","volume":"6","author":"Cho","year":"1989","journal-title":"Pharm. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/S0928-0987(00)00164-0","article-title":"Cell Cultures as Tools in Biopharmacy","volume":"11","author":"Braun","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1021\/acs.molpharmaceut.8b00416","article-title":"Importance of OCT2 and MATE1 for the Cimetidine-Metformin Interaction: Insights from Investigations of Polarized Transport in Single- And Double-Transfected MDCK Cells with a Focus on Perpetrator Disposition","volume":"15","author":"Weitz","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1038\/s41598-018-25139-8","article-title":"Contribution of Multidrug and Toxin Extrusion Protein 1 (MATE1) to Renal Secretion of Trimethylamine-N-Oxide (TMAO)","volume":"8","author":"Gessner","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/00912700122012805","article-title":"Transient Kinetic and Dynamic Interactions between Verapamil and Dofetilide, a Class III Antiarrhythmic","volume":"41","author":"Johnson","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0889-7204.2001.00595.x","article-title":"Dofetilide: A New Class III Antiarrhythmic for the Management of Atrial Fibrillation","volume":"16","author":"Diaz","year":"2001","journal-title":"Prog. Cardiovasc. Nurs."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2125.2000.00114.x","article-title":"Effect of Cimetidine and Ranitidine on Pharmacokinetics and Pharmacodynamics of a Single Dose of Dofetilide","volume":"49","author":"Abel","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.apsb.2016.07.013","article-title":"Renal Drug Transporters and Their Significance in Drug-Drug Interactions","volume":"6","author":"Yin","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000092212","article-title":"Renal Tubular Drug Transporters","volume":"103","author":"Izzedine","year":"2006","journal-title":"Nephron. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1002\/jcph.735","article-title":"Renal Transporter-Mediated Drug-Drug Interactions: Are They Clinically Relevant?","volume":"56","author":"Lepist","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00280-016-3086-7","article-title":"New Insights into Renal Toxicity of the B-RAF Inhibitor, Vemurafenib, in Patients with Metastatic Melanoma","volume":"78","author":"Teuma","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaoncol.2015.1713","article-title":"Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib","volume":"1","author":"Jhaveri","year":"2015","journal-title":"JAMA Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/jcmm.12922","article-title":"Different Effect of Testosterone and Oestrogen on Urinary Excretion of Metformin via Regulating OCTs and MATEs Expression in the Kidney of Mice","volume":"20","author":"He","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"444","DOI":"10.18097\/pbmc20206606444","article-title":"Evaluation of female sex hormones influence on the protein-transporter p-glycoprotein functioning in vitro","volume":"66","author":"Shchulkin","year":"2020","journal-title":"Biomeditsinskaia Khimiia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2165\/00002018-200326060-00004","article-title":"Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs","volume":"26","author":"Yamreudeewong","year":"2003","journal-title":"Drug Saf."},{"key":"ref_50","unstructured":"(2022, April 20). TIKOSYN\u00ae Clinical Pharmacology (Dofetilide)|Pfizer Medical Information\u2014US. Available online: https:\/\/www.pfizermedicalinformation.com\/en-us\/tikosyn\/clinical-pharmacology."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1158\/2767-9764.CRC-21-0076","article-title":"Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A Inhibition","volume":"1","author":"Eisenmann","year":"2021","journal-title":"Cancer Res. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1124\/dmd.118.080424","article-title":"Application of Physiologically Based Pharmacokinetic Modeling in Understanding Bosutinib Drug-Drug Interactions: Importance of Intestinal P-Glycoprotein","volume":"46","author":"Yamazaki","year":"2018","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/clpt.2011.320","article-title":"The Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review","volume":"91","author":"Huang","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.1013","article-title":"Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective","volume":"104","author":"Shebley","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-pharmtox-010510-100540","article-title":"Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science","volume":"51","author":"Rowland","year":"2011","journal-title":"Annu Rev. Pharmacol. Toxicol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cpt.37","article-title":"Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development: A Pharmaceutical Industry Perspective","volume":"97","author":"Jones","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_57","unstructured":"US Food and Drug Administration (2022, August 02). Clinical Drug Interaction Studies\u2014Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions. Guidance for Industry, Available online: https:\/\/www.fda.gov\/media\/134581\/download."},{"key":"ref_58","unstructured":"US Food and Drug Administration (2022, August 02). In Vitro Metabolism and Transporter Mediated Drug-Drug Interaction Studies. Guidance for Industry (Draft), Available online: https:\/\/www.fda.gov\/files\/drugs\/published\/In-Vitro-Metabolism--and-Transporter--Mediated-Drug-Drug-Interaction-Studies-Guidance-for-Industry.pdf."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/clpt.2010.298","article-title":"Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation during Regulatory Review","volume":"89","author":"Zhao","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3109\/00498259209053133","article-title":"Pharmacokinetics and Metabolism of Dofetilide in Mouse, Rat, Dog and Man","volume":"22","author":"Smith","year":"1992","journal-title":"Xenobiotica Fate Foreign Compd. Biol. Syst."},{"key":"ref_61","unstructured":"US Food and Drug Administration (2022, August 02). Drug Approval Package: Tikosyn (Dofetilide) NDA# 20-931; 1999, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/99\/20-931_Tikosyn.cfm."},{"key":"ref_62","unstructured":"(2022, August 02). Pfizer Pharmaceutical Production Limited Tikosyn (Dofetilide, UK-68,798) Capsules: Clinical Pharmacology and Biopharmaceutics Review(s)_Part 1.Pdf, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/99\/20-931_Tikosyn_biopharmr_P1.pdf."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Uddin, M.E., Talebi, Z., Chen, S., Jin, Y., Gibson, A.A., Noonan, A.M., Cheng, X., Hu, S., and Sparreboom, A. (2021). In Vitro and In Vivo Inhibition of MATE1 by Tyrosine Kinase Inhibitors. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13122004"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1073\/pnas.1424313112","article-title":"Mitigation of Acute Kidney Injury by Cell-Cycle Inhibitors That Suppress Both CDK4\/6 and OCT2 Functions","volume":"112","author":"Pabla","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1305321110","article-title":"Oxaliplatin-Induced Neurotoxicity Is Dependent on the Organic Cation Transporter OCT2","volume":"110","author":"Sprowl","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e2020168118","DOI":"10.1073\/pnas.2020168118","article-title":"Targeting OCT3 Attenuates Doxorubicin-Induced Cardiac Injury","volume":"118","author":"Huang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1476-5381.2010.01052.x","article-title":"Double-Transfected MDCK Cells Expressing Human OCT1\/MATE1 or OCT2\/MATE1: Determinants of Uptake and Transcellular Translocation of Organic Cations","volume":"163","author":"Zolk","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1113\/jphysiol.2013.264689","article-title":"Genetic Ablation of Ryanodine Receptor 2 Phosphorylation at Ser-2808 Aggravates Ca2+-Dependent Cardiomyopathy by Exacerbating Diastolic Ca2+ Release","volume":"592","author":"Liu","year":"2014","journal-title":"J. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"20463","DOI":"10.1038\/s41598-020-77562-5","article-title":"Vascular Endothelial Growth Factor Promotes Atrial Arrhythmias by Inducing Acute Intercalated Disk Remodeling","volume":"10","author":"Mezache","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1085\/jgp.201711909","article-title":"Tetrodotoxin-Sensitive Navs Contribute to Early and Delayed Afterdepolarizations in Long QT Arrhythmia Models","volume":"150","author":"Koleske","year":"2018","journal-title":"J. Gen. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/S0024-3205(03)00137-1","article-title":"Age and Anesthetic Effects on Murine Electrocardiography","volume":"72","author":"Chaves","year":"2003","journal-title":"Life Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1021\/mp200395f","article-title":"Deficiency of Multidrug and Toxin Extrusion 1 Enhances Renal Accumulation of Paraquat and Deteriorates Kidney Injury in Mice","volume":"8","author":"Li","year":"2011","journal-title":"Mol. Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.ajpath.2011.02.020","article-title":"Selective Regulation of Cardiac Organic Cation Transporter Novel Type 2 (OCTN2) in Dilated Cardiomyopathy","volume":"178","author":"Grube","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"644342","DOI":"10.3389\/fphar.2021.644342","article-title":"Influence of YES1 Kinase and Tyrosine Phosphorylation on the Activity of OCT1","volume":"12","author":"Uddin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e3056","DOI":"10.21769\/BioProtoc.3056","article-title":"Murine Pharmacokinetic Studies","volume":"8","author":"Leblanc","year":"2018","journal-title":"Bio-Protocol"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpba.2019.04.041","article-title":"Development and Validation of a UPLC-MS\/MS Analytical Method for Dofetilide in Mouse Plasma and Urine, and Its Application to Pharmacokinetic Study","volume":"172","author":"Uddin","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Sugiyama, Y., and Steffansen, B. (2013). Accounting for Transporters in Renal Clearance: Towards a Mechanistic Kidney Model (Mech KiM). Transporters in Drug Development: Discovery, Optimization, Clinical Study and Regulation, Springer.","DOI":"10.1007\/978-1-4614-8229-1"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8607\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:01:41Z","timestamp":1760140901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":77,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23158607"],"URL":"https:\/\/doi.org\/10.3390\/ijms23158607","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]}}}